Search results for "ALZHEIMER"

showing 10 items of 706 documents

MRS SHOWS ABNORMALITIES BEFORE SYMPTOMS IN FAMILIAL ALZHEIMER DISEASE

2006

Background: Pathologic change in Alzheimer disease (AD) begins some years before symptoms. MRS has the potential to detect metabolic abnormalities reflecting this early pathologic change. Presenilin 1 (PS1) and amyloid precursor protein (APP) mutation carriers have a nearly 100% risk of developing AD and may be studied prior to symptom onset. Methods: Short echo time proton MR spectra were acquired from a midline posterior cingulate voxel in presymptomatic carriers of PS1 or APP mutations (“presymptomatic mutation carriers” [PMCs]; n = 7) and age- and sex-matched control subjects (n = 6). Ratios of N-acetyl aspartate (NAA), myo-inositol (MI), and choline-containing compounds (Cho) to creati…

AdultMalemedicine.medical_specialtyPathologyMagnetic Resonance SpectroscopyAlzheimer disease brain metabolism nuclear magnetic resonance spectroscopyAdolescentNeuropsychological TestsCreatineGastroenterologyPresenilinCentral nervous system diseasechemistry.chemical_compoundDegenerative diseaseAlzheimer DiseaseReference ValuesInternal medicinemental disordersmedicineHumansFamilySymptom onsetAge of OnsetChildSettore M-PSI/02 - Psicobiologia E Psicologia FisiologicaBrainInfantMiddle Agedmedicine.diseaseControl subjectsnervous system diseasesnervous systemchemistryChild PreschoolCarrier StateFemaleNeurology (clinical)Alzheimer's diseaseGeometric meanPsychology
researchProduct

Monitoring cognitive changes: Psychometric properties of six cognitive tests

2004

Objectives. Repeated neuropsychological assessments are often used to monitor change in cognitive functioning over time. Thus, knowledge about the reliability and stability of neuropsychological tests and the effects of age and IQ is of paramount importance. In this study we document, for six cognitive tests: test-retest reliabilities, practice effects, reliable change (RC) indices corrected for practice, and the impact of premorbid IQ and age. Design. A sample of 188 normal adults (aged 40-70 years) were administered, on two occasions, one or more of the following tests: the Graded Naming Test (GNT), the Silhouettes Test, two tests of verbal fluency, the Modified Wisconsin Card Sorting Tes…

AdultMalemedicine.medical_specialtyPsychometricsBRAIN-INJURYTest validityNeuropsychological TestsAudiologyNAMING TESTNational Adult Reading TestSeverity of Illness IndexMEMORY TESTDevelopmental psychologyDEMOGRAPHIC-VARIABLESTEST-PERFORMANCEmedicineHumansLONGITUDINAL PROFILESAchievement testVerbal fluency testAgedCARD SORTING TESTSettore M-PSI/02 - Psicobiologia E Psicologia FisiologicaIntelligence quotientmedicine.diagnostic_testReproducibility of ResultsGeneral MedicineNeuropsychological testMiddle AgedCognitive testTest (assessment)ALZHEIMERS-DISEASEVERBAL FLUENCYClinical PsychologyPractice PsychologicalFemaleTEST-RETEST RELIABILITYCognition DisordersPsychologyGraded Naming Test Silhouettes Test Verbal fluency tests Modified Wisconsin Card Sorting Test New Symbol Digit Test National Adult Reading Test (NART)
researchProduct

Corpus callosum area in patients with bipolar disorder with and without psychotic features: an international multicentre study

2015

Background Previous studies have reported MRI abnormalities of the corpus callosum (CC) in patients with bipolar disorder (BD), although only a few studies have directly compared callosal areas in psychotic versus nonpsychotic patients with this disorder. We sought to compare regional callosal areas in a large international multicentre sample of patients with BD and healthy controls. Methods We analyzed anatomic T-1 MRI data of patients with BD-I and healthy controls recruited from 4 sites (France, Germany, Ireland and the United States). We obtained the mid-sagittal areas of 7 CC subregions using an automatic CC delineation. Differences in regional callosal areas between patients and contr…

AdultMaleoasis brain databasePediatricsmedicine.medical_specialtyBipolar DisorderNeuroimagingshapeLithiumCorpus callosumearly alzheimers-diseasesizeCorpus CallosumGermanyImage Processing Computer-AssistedmedicineHumansPharmacology (medical)In patientBipolar disorderPsychiatryCognitive impairmentmriBiological Psychiatrycognitive impairmentreliabilitymedicine.diagnostic_testExtramuralbusiness.industryMagnetic resonance imagingMiddle Agedmedicine.diseaseMagnetic Resonance ImagingWhite MatterUnited States3. Good healthDiagnostic and Statistical Manual of Mental DisordersPsychiatry and Mental healthMulticenter studyLinear ModelsFemaleabnormalitiesFrancei disorderbusinessrating-scaleIrelandResearch PaperAntipsychotic AgentsJournal of Psychiatry and Neuroscience
researchProduct

Volatile organic compounds fingerprint of Alzheimer’s disease.

2015

Alzheimer's disease (AD) is a profoundly life changing condition and once diagnosis occurs, this is typically at a relatively late stage into the disease process. Therefore, a shift to earlier diagnosis, which means several decades before the onset of the typical manifestation of the disease, will be an important step forward for the patient. A promising diagnostic and screening tool to answer this purpose is represented by breath and exhaled volatile organic compounds (VOCs) analysis. In fact, human exhaled breath contains several thousand of VOCs that vary in abundance and number in correlation with the physiological status. The exhaled VOCs reflect the metabolism, including the neuronal …

AdultPulmonary and Respiratory MedicinePathologymedicine.medical_specialtyTime FactorsPhysiologyDiseaseVolatile organic compounds (VOCs)Neurodegenerative diseaseAlzheimer's disease; Breath analysis; Neurodegenerative disease; VOC fingerprint; VOC real time analysis; Volatile organic compounds (VOCs); Adult; Aged; Aged 80 and over; Alzheimer Disease; Biomarkers; Breath Tests; Humans; Middle Aged; Respiratory Rate; Time Factors; Volatile Organic Compounds; Young Adult; Neuroscience (all); Physiology; Pulmonary and Respiratory MedicineYoung AdultRespiratory RateAlzheimer DiseaseVOC fingerprintmedicine80 and overHumansDisease processScreening toolAgedAged 80 and overVolatile Organic CompoundsNeuroscience (all)ChemistryGeneral NeuroscienceLate stageBreath analysisAlzheimer's diseaseMiddle AgedAlzheimer's disease; Breath analysis; Neurodegenerative disease; VOC fingerprint; VOC real time analysis; Volatile organic compounds (VOCs)Breath gas analysisBreath TestsImmunologyVOC real time analysisBiomarkers
researchProduct

Double Negative (CD19+IgG+IgD-CD27-) B Lymphocytes: A New Insight from Telomerase in Healthy Elderly, in Centenarian Offspring, and in Alzheimer’s Di…

2014

Background: We have previously reported the increase of IgD-CD27- (Double Negative, DN) B cell population in the aged. These memory B cells have short telomeres and poor abilities to proliferate in vitro. Here, we investigated whether the low ability of DN B cells to proliferate depends on the expression levels of the CD307d and CD22 inhibitory receptors or whether DN B cells can proliferate and reactivate telomerase by the engagement of both innate and adaptive immune receptors. Methods: Phenotypic analyses were made by using flow cytometry. Quantitative analysis of telomerase activity was made by using a TRAP and a photometric enzyme immunoassay in young, healthy elderly, centenarian offs…

AdultTelomeraseAgingImmunologyPopulationNaive B cellB-Lymphocyte SubsetsReceptors Antigen B-CellCentenarian offspringLymphocyte ActivationSeverity of Illness IndexCD19ImmunophenotypingYoung AdultAlzheimer DiseasemedicineIgD-CD27- (Double Negative DN) B cell population in the aged DN B cell telomerase activity in young elderly CO and AD patientsImmunology and AllergySettore MED/05 - Patologia ClinicaHumanseducationTelomeraseB cellCellular SenescenceAgedInflammationSettore MED/04 - Patologia GeneraleAged 80 and overeducation.field_of_studyCD40biologyB lymphocyteAge FactorsTLR9ImmunosenescenceMiddle Agedmedicine.anatomical_structurePhenotypeImmunologyAntigens Surfacebiology.proteinAlzheimerAging; Telomerase; B lymphocytes; Alzheimer; Centenarian offspring; InflammationSettore MED/26 - NeurologiaImmunologic Memory
researchProduct

Mitochondrial transcriptional study of the effect of aflatoxins, enniatins and carotenoids in vitro in a blood brain barrier model

2020

C. maxima (var. Delica), a variety of pumpkin, is well known for its high concentration on carotenoids, possessing dietary benefits and antioxidant properties. Aflatoxins and enniatins are common mycotoxins present in food and feed with an extended toxicity profile in humans and animals. Both types of substances reach a wide range of tissues and organs and have the capability to penetrate the blood brain barrier. Since carotenoids and mycotoxins have been reported to modify diverse mitochondrial processes individually, transcriptional in vitro studies on human epithelial cells ECV 304 were conducted to analyze the relative expression of 13 mitochondria related genes. ECV 304 cells were diff…

AflatoxinMitochondrial DNAAntioxidantmedicine.medical_treatmentAlzheimer Antioxidants Mycotoxicity Neurodegenerative diseases Carotenoids qPCR ECV 304MitochondrionToxicologyBlood–brain barrierAntioxidantsCell LineNOchemistry.chemical_compoundAflatoxinsCucurbitaDepsipeptidesHuman Umbilical Vein Endothelial CellsmedicineHumansECV 304MycotoxinMycotoxicityCarotenoidchemistry.chemical_classificationLS9_6Neurodegenerative diseasesfood and beveragesGeneral MedicineCarotenoidsIn vitroMitochondriaqPCRmedicine.anatomical_structureElectron Transport Chain Complex ProteinschemistryBiochemistryBlood-Brain BarrierAlzheimerFood Science
researchProduct

Gaussian Mixture Models and Model Selection for [18F] Fluorodeoxyglucose Positron Emission Tomography Classification in Alzheimer’s Disease

2015

We present a method to discover discriminative brain metabolism patterns in [18F] fluorodeoxyglucose positron emission tomography (PET) scans, facilitating the clinical diagnosis of Alzheimer's disease. In the work, the term "pattern" stands for a certain brain region that characterizes a target group of patients and can be used for a classification as well as interpretation purposes. Thus, it can be understood as a so-called "region of interest (ROI)". In the literature, an ROI is often found by a given brain atlas that defines a number of brain regions, which corresponds to an anatomical approach. The present work introduces a semi-data-driven approach that is based on learning the charac…

Aged 80 and overMaleMILD COGNITIVE IMPAIRMENTScience & TechnologyPREDICTIONGeneral Science & TechnologyNormal DistributionBrainModels TheoreticalDIAGNOSISSensitivity and SpecificityMultidisciplinary SciencesPETAlzheimer DiseaseFluorodeoxyglucose F18Positron-Emission TomographyMD MultidisciplinaryHumansScience & Technology - Other TopicsFemaleRadiopharmaceuticalsResearch ArticleAged
researchProduct

Quality of Life in Dementia: Impact of Cognition and Insight on Applicability of the SF-36

2011

Comparability of measures of quality of life in dementia and in other diagnostic groups, such as mild cognitive impairment, normal aging, or other diseases, is highly desirable. However, the impact of cognitive deficits and impaired insight on applicability and validity of generic instruments is sparsely studied.Sixty patients with dementia [38 women; age: mean (SD) = 78.7 (6.4) years; Mini-Mental State Examination (MMSE): mean (SD) = 20.2 (6.0)] recruited as part of the start-modem study, a multicenter care research study in Germany, completed the generic instrument SF-36 and the specific instrument Quality of Life-Alzheimer's Disease (QOL-AD).QOL-AD self-rating scores [mean (SD) = 32.8 (5…

Aged 80 and overMalePsychometricsSF-36MEDLINEReproducibility of ResultsCognitionDiseaseMiddle Agedmedicine.diseasePsychiatry and Mental healthQuality of lifeCronbach's alphaAlzheimer DiseaseQuality of LifemedicineHumansImpaired insightDementiaDementiaFemaleGeriatrics and GerontologyPsychologyAgedClinical psychologyThe American Journal of Geriatric Psychiatry
researchProduct

Immunological and immunogenetic markers of successful and unsuccessful ageing

2002

AgeingCRP - C-reactive proteinImmunologyBiologyAD - Alzheimer's disease
researchProduct

Oxidative Stress in Neurodegenerative Diseases: From a Mitochondrial Point of View

2019

Age is the main risk factor for a number of human diseases, including neurodegenerative disorders such as Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis, which increasing numbers of elderly individuals suffer. These pathological conditions are characterized by progressive loss of neuron cells, compromised motor or cognitive functions, and accumulation of abnormally aggregated proteins. Mitochondrial dysfunction is one of the main features of the aging process, particularly in organs requiring a high-energy source such as the heart, muscles, brain, or liver. Neurons rely almost exclusively on the mitochondria, which produce the energy required for most of the cel…

AgingAntioxidantMitochondrial Diseasesmedicine.medical_treatmentneurodegeneration oxidative stress mitochondiaDiseaseReview ArticleMitochondrionBiologymedicine.disease_causeBiochemistryAntioxidantsAlzheimer DiseasemedicineHumansAmyotrophic lateral sclerosislcsh:QH573-671lcsh:CytologyNeurodegenerationParkinson DiseaseCell BiologyGeneral Medicinemedicine.diseaseMitochondriaOxidative Stressmedicine.anatomical_structureSynaptic plasticityNeuronNeuroscienceOxidative stress
researchProduct